Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Expected to Grow Between 2025 And 2029?
The market size for ribose-nucleic acid (rna)-based therapeutics has seen significant growth recently. There is projected growth from $15.79 billion in 2024, up to $17.22 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.0%. The expansion during the historic period can be linked to growth in investment and funding, the discovery of RNA interference (RNAi), the clinical victories of antisense oligonucleotides (ASOs), regulatory support and established frameworks, as well as collaborations and partnerships.
The market size for ribose-nucleic acid (RNA)-based therapeutics is anticipated to experience significant expansion in the coming years, growing to an estimated $24.11 billion in 2029, with a compound annual growth rate (CAGR) of 8.8%. Various factors driving this growth during the forecast period include expanding indications, increased market demand, and adoption, regulatory encouragement, the inclusion of artificial intelligence and machine learning, and new applications for rare diseases. Key trends during this period encompass advanced delivery systems, RNA therapies targeting multiple areas, personalized RNA treatments, regulatory improvements, and market growth and commercialization.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
What Are the Core Growth Drivers Propelling the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Forward?
The escalating occurrence of cancer is predicted to fuel the expansion of the ribose-nucleic acid (RNA)-based therapeutics market. Cancer is a disease characterized by the abnormal and uncontrolled growth of cells, which can cause death if not treated. It’s growth is attributed to an aging population, changes in lifestyle, increased exposure to risks, and improved detection techniques. RNA-based therapeutics offer a significant pathway for cancer treatment as they directly target the genetic and molecular causes of cancer. For instance, the Australian Institute of Health and Welfare, a governmental health organization in Australia, reported that approximately 151,000 people were diagnosed with cancer in 2021 (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin), a figure expected to rise to 185,000 by 2030. Consequently, the rising occurence of cancer is propelling the growth of the ribose-nucleic acid (RNA)-based therapeutics market.
What Segment Types Define the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Structure?
The ribose-nucleic acid (rna)-based therapeuticsmarket covered in this report is segmented –
1) By Type: RNA Interference (RNAi); RNA Antisense
2) By Technology: Enabling Technology; Enabled Technology
3) By Therapeutic Area: Oncology; Genetic Disorder; Ophthalmology; Hematological Disorders; Acute Hepatic Porphyria (AHP); Other Therapeutic Areas
4) By End User: Research Institutes; Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA); MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs); Antisense RNA
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theRibose-Nucleic Acid (RNA)-Based Therapeutics Industry Evolution?
Leading players in the RNA-based therapeutics market are concentrating on the creation of innovative medicinal solutions such as mRNA-based booster vaccines. The aim is to augment immunization efficiency, adapt to new viral strains, and heighten the longevity of the immunity provided by vaccines. mRNA booster vaccines rely on messenger RNA to stimulate cells into producing a protein that amplifies the body’s defense against specific pathogens. To illustrate, Gennova Biopharmaceuticals Ltd., a pharmaceutical firm from India, introduced GEMCOVAC-OM, the country’s inaugural mRNA booster vaccine aimed at the Omicron variant of COVID-19, in June 2023. This booster becomes necessary in light of the restricted effectiveness of the initial vaccines against Omicron. Employing mRNA technology, GEMCOVAC-OM strengthens immunity and provides superior protection against the continuously mutating virus.
View the full report here:
What Is the Definition of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model